Valuation: EMVision Medical Devices Ltd

Market Cap 145M 101M 88.41M 81.43M 75.59M 144M 9.63B 975M 379M 4.73B 379M 371M 16.39B P/E 2026 *
-16x
P/E 2027 * -13.8x
Enterprise Value 145M 101M 88.41M 81.43M 75.59M 144M 9.63B 975M 379M 4.73B 379M 371M 16.39B EV / Sales 2026 *
26.5x
EV / Sales 2027 * 29.1x
Free-Float
66.78%
Yield 2026 *
-
Yield 2027 * -
1 day-0.32%
1 week+3.30%
Current month+3.30%
1 month-4.57%
3 months-2.19%
6 months-17.63%
Current year-12.08%
1 week 1.47
Extreme 1.47
1.58
1 month 1.47
Extreme 1.47
1.66
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.13
Extreme 1.13
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap.
04-23Buy

Director

10,000 0.0108%
01-02Expiration

Chairman

300,000 0.3228%
11-18Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%+3.30%-10.57%+34.33% 101M
-1.34%+1.81%+23.13%-0.34% 195B
+2.33%+6.74%-18.96%+31.26% 151B
-2.10%+0.23%-3.21%-17.56% 140B
-0.32%+2.50%-57.08%-15.72% 67.09B
+0.85%+4.01%+23.67%+4.84% 54.34B
-0.26%+2.41%-25.15%-29.38% 44.63B
-0.65%+2.07%+8.59%+42.08% 37.24B
+0.15%-1.38%+9.85%+10.61% 36.91B
+4.73%+10.60%-14.41%+2.07% 30.24B
Average +0.34%+2.83%-6.41%+6.22% 75.6B
Weighted average by Cap. -0.06%+3.44%-2.95%+2.79%

Financials

2026 *2027 *
Net sales 5.5M 3.82M 3.34M 3.08M 2.86M 5.43M 364M 36.85M 14.34M 179M 14.33M 14.02M 620M 5M 3.47M 3.04M 2.8M 2.6M 4.93M 331M 33.5M 13.04M 162M 13.03M 12.74M 563M
Net income -9.1M -6.31M -5.53M -5.09M -4.73M -8.98M -602M -60.97M -23.73M -296M -23.71M -23.19M -1.03B -12M -8.33M -7.29M -6.72M -6.23M -11.84M -794M -80.41M -31.29M -390M -31.27M -30.58M -1.35B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
06/07/26 A$1.565 -0.32% 16,527
03/07/26 A$1.570 +3.97% 51,475
02/07/26 A$1.510 +1.34% 23,215
01/07/26 A$1.490 -1.65% 25,475
30/06/26 A$1.515 +0.66% 131,705
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.565AUD
Average target price
3.150AUD
Spread / Average Target
+101.28%

Annual profits - Rate of surprise